Abstract
Hypertension is the most important risk factor for cerebral small vessel disease (SVD). In this cross-sectional study, we tested the independent association of cerebral SVD burden with global cognitive function and each cognitive domain in patients with vascular risk factors. The Tokyo Women’s Medical University Cerebral Vessel Disease (TWMU CVD) registry is an ongoing prospective, observational registry in which patients with any evidence of CVD in magnetic resonance imaging (MRI) and at least one vascular risk factor were consecutively enrolled. For SVD-related findings, we evaluated white matter hyperintensity, lacunar infarction, cerebral microbleeds, enlarged perivascular space, and medial temporal atrophy. We used the total SVD score as the SVD burden. They underwent the Mini-mental State Examination (MMSE) and Japanese version of the Montreal Cognitive Assessment (MoCA-J) global cognitive tests, and each cognitive domain was evaluated. After excluding patients without MRI T2* images and those with MMSE score <24, we analyzed 648 patients. The total SVD score was significantly associated with MMSE and MoCA-J scores. After adjustment for age, sex, education, risk factors, and medial temporal atrophy, the association between the total SVD score and MoCA-J score remained significant. The total SVD score was independently associated with attention. In conclusion, the total SVD score, cerebral SVD burden, was independently association with global cognitive function and attention. A strategy to reduce SVD burden will have the potential to prevent cognitive decline.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6:611–9.
Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.
Akoudad S, Portegies MLP, Koudstaal PJ, Hofman A, van der Lugt A, Ikram MA, et al. Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam Study. Circulation. 2015;132:509–16.
Akoudad S, Wolters FJ, Viswanathan A, de Bruijn EF, van der Lugt A, Hofman A, et al. Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol. 2016;73:934–43.
Hamilton OKL, Backhouse EV, Janssen E, Jochems ACC, Maher C, Ritakari TE, et al. Cognitive impairment in sporadic cerebral small vessel disease: a systematic review and meta-analysis. Alzheimers Dement. 2021;17:665–85.
Kitagawa K. Blood pressure management for secondary stroke prevention. Hypertens Res. 2022;45:936–43.
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38.
Zamboni G, Griffanti L, Jenkinson M, Mazzucco S, Li L, Küker W, et al. White matter imaging correlates of early cognitive impairment detected by the montreal cognitive assessment after transient ischemic attack and minor stroke. Stroke. 2017;48:1539–47.
Hoshi T, Yamagami H, Furukado S, Miwa K, Tanaka M, Sakaguchi M, et al. Serum inflammatory proteins and frontal lobe dysfunction in patients with cardiovascular risk factors. Eur J Neurol. 2010;17:1134–40.
Yakushiji Y, Nishiyama M, Yakushiji S, Hirotsu T, Uchino A, Nakajima J, et al. Brain microbleeds and global cognitive function in adults without neurological disorder. Stroke. 2008;39:3323–8.
Hilal S, Tan CS, Adams HHH, Habes M, Mok V, Venketasubramanian N, et al. Enlarged perivascular spaces and cognition: a meta-analysis of 5 population-based studies. Neurology. 2018;91:e832–e842.
Huijts M, Duits A, van Oostenbrugge RJ, Kroon AA, de Leeuw PW, Staals J. Accumulation of MRI markers of cerebral small vessel disease is associated with decreased cognitive function. a study in first-ever lacunar stroke and hypertensive patients. Front Aging Neurosci. 2013;5:72.
Klarenbeek P, van Oostenbrugge RJ, Rouhl RP, Knottnerus IL, Staals J. Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease. Stroke 2013;44:2995–9.
Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228–34.
Staals J, Booth T, Morris Z, Bastin ME, Gow AJ, Corley J, et al. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol Aging. 2015;36:2806–11.
Uiterwijk R, van Oostenbrugge RJ, Huijts M, De Leeuw PW, Kroon AA, Staals J. Total cerebral small vessel disease MRI score is associated with cognitive decline in executive function in patients with hypertension. Front Aging Neurosci. 2016;8:301.
Lau KK, Li L, Schulz U, Simoni M, Chan KH, Ho SL, et al. Total small vessel disease score and risk of recurrent stroke: Validation in 2 large cohorts. Neurology. 2017;88:2260–7.
Yilmaz P, Ikram MK, Niessen WJ, Ikram MA, Vernooij MW. Practical small vessel disease score relates to stroke, dementia, and death. Stroke. 2018;49:2857–65.
Suzuyama K, Yakushiji Y, Ogata A, Nishihara M, Eriguchi M, Kawaguchi A, et al. Total small vessel disease score and cerebro-cardiovascular events in healthy adults: the Kashima scan study. Int J Stroke. 2020;15:973–9.
Zhi N, Zhang L, Wang Y, Bai S, Geng J, Yu L, et al. Modified cerebral small vessel disease score is associated with vascular cognitive impairment after lacunar stroke. Aging. 2021;13:9510–21.
Serrano-Pozo A, Growdon JH. Is Alzheimer’s disease risk modifiable? J Alzheimers Dis. 2019;67:795–819.
Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6:67–77.
Litak J, Mazurek M, Kulesza B, Szmygin P, Litak J, Kamieniak P, et al. Cerebral small vessel disease. Int J Mol Sci. 2020;21:9729.
Kubota M, Iijima M, Shirai Y, Toi S, Kitagawa K. Association between cerebral small vessel disease and central motor conduction time in patients with vascular risk. J Stroke Cerebrovasc Dis. 2019;28:2343–50.
Seki M, Yoshizawa H, Hosoya M, Kitagawa K. Neuropsychological profile of early cognitive impairment in cerebral small vessel disease. Cerebrovasc Dis. 2022;51:600–7.
Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, et al. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int. 2010;10:225–32.
Kim GH, Kim JE, Choi KG, Lim SM, Lee JM, Na DL, et al. T1-weighted axial visual rating scale for an assessment of medial temporal atrophy in Alzheimer’s disease. J Alzheimers Dis. 2014;41:169–78.
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol. 1987;149:351–6.
Doubal FN, MacLullich AMJ, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41:450–4.
Vasquez BP, Zakzanis KK. The neuropsychological profile of vascular cognitive impairment not demented: a meta-analysis. J Neuropsychol. 2015;9:109–36.
Ishikawa H, Meguro K, Ishii H, Tanaka N, Yamaguchi S. Silent infarction or white matter hyperintensity and impaired attention task scores in a nondemented population: the Osaki-Tajiri Project. J Stroke Cerebrovasc Dis. 2012;21:275–82.
Carey CL, Kramer JH, Josephson SA, Mungas D, Reed BR, Schuff N, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke. 2008;39:397–402.
Hirao K, Yamashita F, Tsugawa A, Haime R, Fukasawa R, Sato T, et al. Association of white matter hyperintensity progression with cognitive decline in patients with amnestic mild cognitive impairment. J Alzheimers Dis. 2021;80:877–83.
Jiang J, Yao K, Huang X, Zhang Y, Shen F, Weng S. Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke. Aging Clin Exp Res. 2022;34:1047–54.
Funding
This work was supported in part by Research Funding of Longevity Sciences (28-15, 30-1) from the National Center for Geriatrics and Gerontology, the Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
KK reports personal fees from Daiichi Sankyo, Kyowa Kirin and Kowa. Others have nothing to disclose.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hosoya, M., Toi, S., Seki, M. et al. Association between total cerebral small vessel disease score and cognitive function in patients with vascular risk factors. Hypertens Res 46, 1326–1334 (2023). https://doi.org/10.1038/s41440-023-01244-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-023-01244-8
Keywords
This article is cited by
-
Small vessels cause big problems
Hypertension Research (2024)